Hospital Universitari Vall d'Hebron-Oncology ( Site 1800)

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Neoplasm Malignant

Studies at this site

• Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016) — Running, not enrolling